Activated Akt expression in breast cancer: Correlation with p53, Hdm2 and patient outcome
Authors:
- C.M. PerksC.M. Perks
- M. PignatelliMPM. Pignatelli
- Z.E. WintersZWZ.E. Winters
- 1 May 2005
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 41 (7) , 1017-1025
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Akt kinases in breast cancer and the results of adjuvant therapyBreast Cancer Research, 2003
- AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survivalOncogene, 2002
- Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patientsBritish Journal of Cancer, 2002
- HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylationNature Cell Biology, 2001
- Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cellsNature Cell Biology, 2001
- Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinaseNature, 2000
- Cellular survival: a play in three AktsGenes & Development, 1999
- Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent ApoptosisJournal of Biological Chemistry, 1999
- Role of AKT1 in 17β-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cellsBiochemical Pharmacology, 1999
- Role of Translocation in the Activation and Function of Protein Kinase BJournal of Biological Chemistry, 1997